Clinical Trials Logo

Early Detection of Cancer clinical trials

View clinical trials related to Early Detection of Cancer.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06021496 Completed - Clinical trials for Early Detection of Cancer

The Effect of Face-to-face and Online Health Education on Women's Cervical Cancer Knowledge, Health Beliefs and Screening

Start date: February 14, 2023
Phase: N/A
Study type: Interventional

Aim: The aim of this study is to determine the effect of health education given by two different methods on women's knowledge about HPV, cervical cancer health belief and screening test. Materials and Methods: The study was conducted in a parallel groups design as a single-blind randomized controlled trial. The sample consisted of 126 healthy participants, 42 in each volunteer group, who were registered at the Martyr Zafer Çalışkan Family Health Center in Ankara between January and July 2023, and met the inclusion criteria. HPV Knowledge scale, Cervical Cancer and pap Smear Test Health Belief Model Scale and VAS for self-assessment were used in the study. In the study, while the control group received standard care, the face-to-face education group was given health education and brochures through home visits and a reminder interview over the phone; On the other hand, the online training group was given health education and a digital brochure via video call and a reminder meeting was held once. One-way analysis of variance and Kruskal Wallis test were used to compare the data of the three groups after a two-month follow-up, Tukey and Dunn test for multiple comparisons, and Wilcoxon test for in-group comparisons before and after. In addition, two-way analysis of variance and Robust ANOVA were used in group and time comparisons.

NCT ID: NCT05622760 Completed - Anxiety Clinical Trials

Impact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening

DICRA
Start date: May 17, 2022
Phase: N/A
Study type: Interventional

When participating in population-based screening for cervical cancer, women experience great anxiety during the weeks of waiting since they learn that they have an altered screening result until the colposcopy is performed. In this study we want to verify how anxiety decreases when the information is improved and an audiovisual support is added when giving it.

NCT ID: NCT05265897 Completed - Lung Cancer Clinical Trials

Improving Implementation of Lung Cancer Screening in Diverse Populations II

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

This project assesses the feasibility, appropriateness, and acceptability of a "Commonly Asked Questions after Lung Cancer Screening" (CAQ) informational document that the investigators created, resulting from patient and provider discussion in focus groups and interviews. If effective, the CAQ may be a new tool to help improve patient understanding of LCS results and adherence to follow-up recommendations.

NCT ID: NCT05163236 Completed - Colonoscopy Clinical Trials

Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening

FITBACK
Start date: April 20, 2021
Phase:
Study type: Observational

Fecal immunochemical test (FIT) was introduced in France late 2015, FIT has better diagnostic accuracy for colorectal cancers (CRCs) than previous screening tests. Our primary objective was to evaluate the sensitivity of FIT and the proportion of interval cancer.

NCT ID: NCT05022511 Completed - Colorectal Cancer Clinical Trials

Three Birds With One Stone

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The overall aim of the study is to increase participation rates in cervical cancer (CCU) and colorectal cancer (CRC) screening programmes in Denmark by offering home-based CCU and CRC screening to women who are overdue for one or both screening programmes when attending breast cancer screening

NCT ID: NCT04688086 Completed - Breast Cancer Clinical Trials

A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers

Start date: December 15, 2018
Phase:
Study type: Observational

The purpose of this study is to determine the clinical performance of AI-based Thermalytix with the current standard-of-care diagnostic modalities in women.

NCT ID: NCT04304404 Completed - Breast Cancer Clinical Trials

Risk Reduction Program for Women Having High Risk of Breast Cancer

BrCaRRP
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

An intervention program involving education, guidance, counseling, case management and surveillance based on the Health Belief Model will be implemented on women with high risk of breast cancer. The impact of the breast cancer risk reduction program on participation in breast cancer screenings, health beliefs (health motivation, sensitivity, fear of breast cancer) and behaviors (physical activity, nutrition, health responsibility, genetic counseling) will be evaluated in the study.

NCT ID: NCT03435380 Completed - Breast Neoplasms Clinical Trials

Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer

Start date: May 7, 2019
Phase: N/A
Study type: Interventional

The primary purpose of this study is to determine the impact of maximizing patient and primary care provider (PCP) activation on breast cancer surveillance rates among women previously treated with chest radiotherapy (RT) for a childhood cancer. This is an 18-month, 3-arm randomized controlled trial using a smartphone intervention with data being collected at baseline and 18-months through patient and provider surveys and medical record review. Eligible women treated for a childhood cancer with chest RT will be randomly sampled from the Childhood Cancer Survivor Study (CCSS) and randomly selected to one of three groups: control, patient activation (PA) using a smartphone-based intervention, or patient activation + primary care provider activation (PA+PCP) which will include physician materials about breast cancer risk in this population along with guidelines for breast cancer surveillance. Participants in all groups will receive mailed targeted print materials as an educational resource about their previous chest radiation and breast cancer screening recommendations. The primary outcome is a medical record confirmed breast MRI and mammogram with the goal of increasing the rate of women completing the national guideline-based recommended combination of breast MRI and mammogram. This study will test the hypothesis that women in the PA and PA+PCP groups will have significantly higher rates of breast cancer surveillance (breast MRI and mammogram) than women in the control group. In addition, the hypothesis that women in the PA+PCP group will have significantly higher rates of breast cancer surveillance than women in the PA group will also be tested.

NCT ID: NCT03124316 Completed - Clinical Trial Clinical Trials

Testing a Behavioural Approach to Improving Cancer Screening Rates

Start date: May 10, 2017
Phase: N/A
Study type: Interventional

Family doctors can play a critical role in successfully arranging cancer screening tests to occur, especially if they know which patients are due for these tests. However, they don't always interact with or take advantage of registry data to this end. For example, in Ontario, the Screening Activity Report provides exactly this information to family doctors, helping them identify their patients who are overdue for screening. Unfortunately, less than half of family doctors regularly use the Screening Activity Report even though they get monthly email reminders. One possible reason is that the reminders they receive are not designed to compel action. They are easy for family doctors to miss or dismiss. This study will compare multiple different ways of designing the reminders. The different versions of the email are tested in a 2^3 factorial trial testing three behaviour change techniques to see which ones will lead to more family physicians interacting with the Screening Activity Report and at increasing the number of patients that get all the appropriate screening tests for cervical, breast, and/or colon cancer.

NCT ID: NCT03122275 Completed - Clinical trials for Early Detection of Cancer

Stepwise Strategy to Improve CANcer Screening Adherence: Cervical Cancer

SCAN-CC
Start date: April 27, 2017
Phase: N/A
Study type: Interventional

This study aims to assess the effectiveness of a stepwise approach, with increasing complexity and cost, to improve adherence to organized cervical cancer screening: step 1a - customized text message invitation; step 1b - customized automatic phone call invitation; step 2 - secretary phone call; step 3 - health professionals face-to-face appointment. A population-based randomized controlled trial will be implemented in Portuguese urban and rural areas. Women eligible for cervical cancer screening will be randomized (1:1) to intervention and control. In the intervention group, women will be invited for screening through text messages, automatic phone calls, manual phone calls and health professional appointments, to be applied sequentially to participants remaining non-adherent after each step. Control will be the standard of care (invitation by written letter). As primary objectives, we intend to test the superiority of interventions based on step 1 (1a+1b) and multistage interventions based on steps 1 and 2 and steps 1 to 3, based on intention-to-treat analyses.